Curcio C - Search Results

1

Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway.

Coscia M, Quaglino E, Iezzi M, Curcio C, Pantaleoni F, Riganti C, Holen I, Mönkkönen H, Boccadoro M, Forni G, Musiani P, Bosia A, Cavallo F, Massaia M. Coscia M, et al. Among authors: curcio c. J Cell Mol Med. 2010 Dec;14(12):2803-15. doi: 10.1111/j.1582-4934.2009.00926.x. J Cell Mol Med. 2010. PMID: 19818098 Free PMC article.

2

Intramammary application of non-methylated-CpG oligodeoxynucleotides (CpG) inhibits both local and systemic mammary carcinogenesis in female BALB/c Her-2/neu transgenic mice.

Mastini C, Becker PD, Iezzi M, Curcio C, Musiani P, Forni G, Cavallo F, Guzmán CA. Mastini C, et al. Among authors: curcio c. Curr Cancer Drug Targets. 2008 May;8(3):230-42. doi: 10.2174/156800908784293604. Curr Cancer Drug Targets. 2008. PMID: 18473736 Free article.

3

Immunological inhibition of carcinogenesis.

Spadaro M, Lanzardo S, Curcio C, Forni G, Cavallo F. Spadaro M, et al. Among authors: curcio c. Cancer Immunol Immunother. 2004 Mar;53(3):204-16. doi: 10.1007/s00262-003-0483-7. Epub 2004 Jan 13. Cancer Immunol Immunother. 2004. PMID: 14722672 Review.

4

Immunosurveillance of Erbb2 carcinogenesis in transgenic mice is concealed by a dominant regulatory T-cell self-tolerance.

Ambrosino E, Spadaro M, Iezzi M, Curcio C, Forni G, Musiani P, Wei WZ, Cavallo F. Ambrosino E, et al. Among authors: curcio c. Cancer Res. 2006 Aug 1;66(15):7734-40. doi: 10.1158/0008-5472.CAN-06-1432. Cancer Res. 2006. PMID: 16885376

5

Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice.

Bandini S, Curcio C, Macagno M, Quaglino E, Arigoni M, Lanzardo S, Hysi A, Barutello G, Consolino L, Longo DL, Musiani P, Forni G, Iezzi M, Cavallo F. Bandini S, et al. Among authors: curcio c. Oncoimmunology. 2013 Sep 1;2(9):e26137. doi: 10.4161/onci.26137. Epub 2013 Sep 12. Oncoimmunology. 2013. PMID: 24228231 Free PMC article.

6

DNA immunization using constant-current electroporation affords long-term protection from autochthonous mammary carcinomas in cancer-prone transgenic mice.

Curcio C, Khan AS, Amici A, Spadaro M, Quaglino E, Cavallo F, Forni G, Draghia-Akli R. Curcio C, et al. Cancer Gene Ther. 2008 Feb;15(2):108-14. doi: 10.1038/sj.cgt.7701106. Epub 2007 Nov 9. Cancer Gene Ther. 2008. PMID: 17992201

7

A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth.

Holmgren L, Ambrosino E, Birot O, Tullus C, Veitonmäki N, Levchenko T, Carlson LM, Musiani P, Iezzi M, Curcio C, Forni G, Cavallo F, Kiessling R. Holmgren L, et al. Among authors: curcio c. Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9208-13. doi: 10.1073/pnas.0603110103. Epub 2006 Jun 5. Proc Natl Acad Sci U S A. 2006. PMID: 16754857 Free PMC article.

8

HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice.

Iezzi M, Quaglino E, Cappello P, Toto V, Sabatini F, Curcio C, Garotta G, Musiani P, Cavallo F. Iezzi M, et al. Among authors: curcio c. Int J Immunopathol Pharmacol. 2011 Jul-Sep;24(3):621-30. doi: 10.1177/039463201102400308. Int J Immunopathol Pharmacol. 2011. PMID: 21978694 Free article.

9

Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.

Quaglino E, Iezzi M, Mastini C, Amici A, Pericle F, Di Carlo E, Pupa SM, De Giovanni C, Spadaro M, Curcio C, Lollini PL, Musiani P, Forni G, Cavallo F. Quaglino E, et al. Among authors: curcio c. Cancer Res. 2004 Apr 15;64(8):2858-64. doi: 10.1158/0008-5472.can-03-2962. Cancer Res. 2004. PMID: 15087404

10

Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity.

Spadaro M, Ambrosino E, Iezzi M, Di Carlo E, Sacchetti P, Curcio C, Amici A, Wei WZ, Musiani P, Lollini PL, Cavallo F, Forni G. Spadaro M, et al. Among authors: curcio c. Clin Cancer Res. 2005 Mar 1;11(5):1941-52. doi: 10.1158/1078-0432.CCR-04-1873. Clin Cancer Res. 2005. PMID: 15756020

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

584 results

Search Page